Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.2811
+0.0521 (22.75%)
At close: Apr 25, 2025, 4:00 PM
0.2650
-0.0161 (-5.73%)
After-hours: Apr 25, 2025, 5:05 PM EDT
Cyclacel Pharmaceuticals Market Cap
Cyclacel Pharmaceuticals has a market cap or net worth of $57.74 million as of April 25, 2025. Its market cap has increased by 2,036.72% in one year.
Market Cap
57.74M
Enterprise Value
54.61M
1-Year Change
2,036.72%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since March 28, 2006, Cyclacel Pharmaceuticals's market cap has increased from $12.30M to $57.74M, an increase of 369.55%. That is a compound annual growth rate of 8.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |